A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.

Yousuf, Fawad; Dupuy, Sheena L; Tauhid, Shahamat; Chu, Renxin; Kim, Gloria; Tummala, Subhash; Khalid, Fariha; Weiner, Howard L; Chitnis, Tanuja; Healy, Brian C; Bakshi, Rohit.
J Neurol Sci; 383: 221-229, 2017 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-29146095